Deep Apple Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $52M

  • Investors
  • 1

Deep Apple General Information

Description

Developer of a drug discovery platform designed to identify small-molecule therapeutics. The company's platform leverages cryo-EM-enabled structural biology, AI-powered pocket extraction, molecular dynamics, protein movement modeling, and ultra-high-volume virtual screening of internally generated libraries, enabling pharmaceutical researchers to quickly identify and advance novel candidates for a broad range of diseases.

Contact Information

Website
www.deepappletx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 230 Park Avenue
  • Suite 2800
  • New York, NY 10169
  • United States
+1 (857)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 230 Park Avenue
  • Suite 2800
  • New York, NY 10169
  • United States
+1 (857)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deep Apple Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Dec-2023 $52M Completed Generating Revenue
1. Early Stage VC (Series A) 22-Dec-2021 Completed Startup
To view Deep Apple’s complete valuation and funding history, request access »

Deep Apple Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Deep Apple’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Deep Apple Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to identify small-molecule therapeutics. The company's platform leverage
Drug Discovery
New York, NY
27 As of 2026

Guilford, CT
 

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Deep Apple Competitors (3)

One of Deep Apple’s 3 competitors is Invea Therapeutics, a Venture Capital-Backed company based in Guilford, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Invea Therapeutics Venture Capital-Backed Guilford, CT
Kyverna Formerly VC-backed Emeryville, CA
SynAct Pharma Formerly VC-backed Lund, Sweden
You’re viewing 3 of 3 competitors. Get the full list »

Deep Apple Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

Deep Apple Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260242367-A1 Substituted amine compounds, compositions and methods of use Pending 20-Feb-2025
US-20260317315-A1 Substituted amine compounds, compositions and methods of use Pending 20-Feb-2025
WO-2026177960-A1 Substituted amine compounds, compositions and methods of use Pending 20-Feb-2025
US-20260132119-A1 Alkylphenyl substituted compounds, compositions and methods of use Pending 08-Nov-2024
WO-2026102082-A1 Alkylphenyl substituted compounds, compositions and methods of use Pending 08-Nov-2024 C07D207/08
To view Deep Apple’s complete patent history, request access »

Deep Apple Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deep Apple Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apple Tree Partners (ATP) Venture Capital Minority
To view Deep Apple’s complete investors history, request access »

Ready to get started?

Request a free trial

Deep Apple FAQs

  • When was Deep Apple founded?

    Deep Apple was founded in 2021.

  • Where is Deep Apple headquartered?

    Deep Apple is headquartered in New York, NY.

  • What is the size of Deep Apple?

    Deep Apple has 27 total employees.

  • What industry is Deep Apple in?

    Deep Apple’s primary industry is Drug Discovery.

  • Is Deep Apple a private or public company?

    Deep Apple is a Private company.

  • What is Deep Apple’s current revenue?

    The current revenue for Deep Apple is .

  • How much funding has Deep Apple raised over time?

    Deep Apple has raised $57M.

  • Who are Deep Apple’s investors?

    Apple Tree Partners (ATP) has invested in Deep Apple.

  • Who are Deep Apple’s competitors?

    Invea Therapeutics, Kyverna, and SynAct Pharma are competitors of Deep Apple.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process